Effects of chronic nicotine treatment on expression of diverse nicotinic acetylcholine receptor subtypes. I. Dose- and time-dependent effects of nicotine treatment

Journal of Pharmacology and Experimental Therapeutics

Volumn 286, Issue 2, 1998, Pages 825-840

  Ke, Lei ^a   Eisenhour, Cynthia M ^a   Bencherif, Merouane ^a,b   Lukas, Ronald J ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b RJR Research and Development   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA BUNGAROTOXIN; NICOTINE TARTRATE; NICOTINIC RECEPTOR; RADIOLIGAND; RECEPTOR SUBTYPE; RECEPTOR SUBUNIT; RUBIDIUM;

ARTICLE; CHOLINERGIC TRANSMISSION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; DRUG EFFECT; DRUG POTENCY; HUMAN; HUMAN CELL; LIGAND BINDING; NEUROBLASTOMA CELL; PRIORITY JOURNAL; RECEPTOR DENSITY; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION;

BLOTTING, NORTHERN; CLONE CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GANGLIA, SYMPATHETIC; HUMANS; MUSCLE, SKELETAL; NICOTINE; NICOTINIC AGONISTS; PROTEIN BIOSYNTHESIS; RADIOLIGAND ASSAY; RECEPTORS, NICOTINIC; RNA, MESSENGER; RUBIDIUM RADIOISOTOPES; TIME FACTORS; UP-REGULATION;

EID: 0032411214     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (44)

1. Beeson D, Morris A, Vincent A and Newsom-Davis J (1990) The human muscle nicotinic acetylcholine receptor α subunit exists as two isoforms: A novel exon. EMBO J 9:2101-2106.
2. Bencherif M, Eisenhour CM, Prince RJ, Lippiello PM and Lukas RJ (1995b) The "calcium antagonist" TMB-8 [3,4,5-trimethoxy benzoic acid 8-(diethylamino)octyl ester] is a potent, non-competitive, functional antagonist at diverse nicotinic acetylcholine receptor subtypes. J Pharmacol Exp Ther 275:1418-1426.
3. Bencherif M, Fowler K, Lukas RJ and Lippiello PM (1995a) Mechanisms of upregulation of neuronal nicotinic acetylcholine receptors in clonal cell lines and primary cultures of fetal rat brain. J Pharmacol Exp Ther 275:987-994.
4. Bencherif M and Lukas RJ (1993) Cytochalasin modulation of nicotinic cholinergic receptor expression and muscarinic receptor function in human TE671/RD cells: A possible functional role of the cytoskeleton. J Neurochem 61:852-864.
5. Bhat RV, Marks MJ and Collins AC (1994) Effects of chronic nicotine infusion on kinetics of high affinity nicotine binding. J Neurochem 62:574-581.
6. Blount P, Smith MM and Merlie JP (1990) Assembly intermediates of the mouse muscle nicotinic acetylcholine receptor in stably transfected fibroblasts. J Cell Biol 111:2601-2611.
7. Carlin BE, Lawrence JC, Lindstrom JM and Merlie JP (1986) An acetylcholine receptor precursor α subunit that binds α-bungarotoxin but not d-tubocurarine. Proc Natl Acad Sci USA 83:498-520.
8. Collins AC and Marks MJ (1996) Are nicotinic acetylcholine receptors activated or inhibited following chronic nicotine treatment? Drug Dev Res 38:231-242.
9. Conroy WG, Saedi MS and Lindstrom J (1990) TE671 cells express an abundance of a partially mature acetylcholine receptor a subunit which has characteristics of an assembly intermediate. J Biol Chem 265:21642-21651.
10. Dani JA and Heinemann S (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16:905-908.
11. Gray JA, Mitchell SN, Joseph MH, Grogoryan GA, Dawe S and Hodges H (1994) Neurochemical mechanisms mediating the behavioral and cognitive effects of nicotine. Drug Dev Res 31:3-17.
12. Henningfield JE, Schuh LM and Heishman SJ (1995) Pharmacological determinants of cigarette smoking. In Effects of Nicotine on Biological Systems II, ed. by PBS Clarke, M Quik, F Adlkofer and K Thurau, pp 127-135, Birkhäuser Verlag, Basel.
13. Hsu Y-N, Amin J, Weiss DS and Wecker L (1996) Sustained nicotine exposure differentially affects α3β2 and α4β2 neuronal nicotinic receptors expressed in Xenopus oocytes. J Neurochem 66:667-675.
14. Hulihan-Giblin BA, Lumpkin MD and Kellar KJ (1990) Effects of chronic administration of nicotine on prolactin release in the rat: inactivation of prolactin response by repeated injections of nicotine. J Pharmacol Exp Ther 252:21-25.
15. Katz B and Thesleff S (1957) A study of the "desensitization" produced by acetylcholine at the motor endplate. J Physiol 138:63-80.
16. Lindstrom J (1996) Neuronal nicotinic acetylcholine receptors. In Ion Channels, ed. by T Narahashi, Vol 4, pp 377-450, Plenum Press, New York.
17. 3H]nicotine binding to putative high affinity receptor sites in rat brain. Mol Pharmacol 31:392-400.
18. Lowry OH, Rosebrough NJ, Farr AL and Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193:265-275.
19. Lukas RJ (1984) Properties of curaremimetic neurotoxin binding sites in the rat central nervous system. Biochem 23:1152-1160.
20. Lukas RJ (1986a) Characterization of curaremimetic neurotoxin binding sites on membrane fractions derived from the human medulloblastoma clonal line, TE671. J Neurochem 46:1936-1941.
21. Lukas RJ (1986b) Immunochemical and pharmacological distinctions between curaremimetic neurotoxin binding sites of central, autonomic, and peripheral origin. Proc Natl Acad Sci USA 83:5741-5745.
22. Lukas RJ (1989) Pharmacological distinctions between functional nicotinic acetylcholine receptors on the PC12 rat pheochromocytoma and the TE671 human medulloblastoma. J Pharmacol Exp Ther 251:175-182.
23. 3H-acetylcholine binding sites. J Pharmacol Exp Ther 253:51-57.
24. Lukas RJ (1991) Effects of chronic nicotinic ligand exposure on functional activity of nicotinic acetylcholine receptors expressed by cells of the PC12 rat pheochromocytoma or the TE671/RD human clonal line. J Neurochem 56:134-145.
25. Lukas RJ (1993) Expression of ganglia-type nicotinic acetylcholine receptors and nicotinic ligand binding sites by cells of the IMR-32 human neuroblastoma clonal line. J Pharmacol Exp Ther 265:294-302.
26. Lukas RJ (1995) Diversity and patterns of regulation of nicotinic receptor subtypes. Ann NY Acad Sci 757:153-168.
27. Lukas RJ (1998) Neuronal nicotinic acetylcholine receptors. In The Nicotinic Acetylcholine receptor: Current Views and Future Trends, ed. by FJ Barrantes, pp 145-173, Landes Bioscience, New York.
28. Lukas RJ, Ke L, Bencherif M and Eisenhour CM (1996) Regulation by nicotine of its own receptors. Drug Dev Res 38:136-148.
29. Lukas RJ, Norman SA and Lucero L (1993) Characterization of nicotinic acetylcholine receptors expressed by cells of the SH-SY5Y human neuroblastoma clonal line. Mol Cell Neurosci 4:1-12.
30. Luther MA, Schoepfer R, Whiting P, Casey B, Blatt Y, Montal MS, Montal M and Lindstrom J (1988) A muscle acetylcholine receptor is expressed in the human cerebellar medulloblastoma cell line TE671. J Neurosci 9:1082-1096.
31. Marks MJ, Burch JB and Collins AC (1983) Effects of chronic nicotine infusion on tolerance development and nicotinic receptors. J Pharmacol Exp Ther 226:816-825.
32. Newland CF, Beeson D, Vincent A and Newsom-Davis J (1995) Functional and non-functional isofonns of the human muscle acetylcholine receptor. J Physiol 489:767-778.
33. Pauly JR, Marks MJ, Robinson SF, van de Kamp JL and Collins AC (1996) Chronic nicotine and mecamylamine treatment increases brain nicotinic receptor binding without changing α4 or β2 mRNA levels. J Pharmacol Exp Ther 278:361-369.
34. Peng X, Anand R, Whiting P and Lindstrom J (1994) Nicotine-induced upregulation of neuronal nicotinic receptors results from a decrease in the rate of turnover. Mol Pharmacol 46:523-530.
35. Peto R, Lopez A, Boreham J, Thun M and Heath C (1992) Mortality from tobacco in developed countries: Indirect estimation from national vital statistics. Lancet 339:1268-1278.
36. Puchacz E, Buisson B, Bertrand D and Lukas RJ (1994) Functional expression of nicotinic acetylcholine receptors containing rat α7 subunits in human neuroblastoma cells. FEBS Lett 354:155-159.
37. Robinson D and McGee R Jr (1985) Agonist-induced regulation of the neuronal nicotinic acetylcholine receptor or PC12 cells. Mol Pharmacol 27:409-417.
38. Rowell PP and Li M (1997) Dose-response relationship for nicotine-induced up-regulation of rat brain nicotinic receptors. J Neurochem 68:1982-1989.
39. 3H] acetylcholine recognition sites in brain by nicotinic cholinergic drugs. J Neurochem 45:427-433.
40. Sharp BM, Beyer HS, Levine AS, Moreley JE and McAllen KM (1987) Attenuation of plasma prolactin response to restraint stress after acute and chronic administration of nicotine to rats. J Pharmacol Exp Ther 241:438-442.
41. Walker R, Vincent A and Newsom-Davis J (1988) Immunological and pharmacological heterogeneity of α-bungarotoxin binding sites extracted from TE671 cells. J Neuroimmunol 19:149-157.
42. Warburton DM (1995) The functional conception of nicotine use. In Effects of Nicotine on Biological Systems II, ed. by PBS Clarke, M Quik, F Adlkofer and K Thurau, pp. 257-264, Birkhäuser Verlag, Basel.
43. Wonnacott S (1990) The paradox of nicotinic acetylcholine receptor upregulation by nicotine. Trends Pharmacol Sci 11:216-219.
44. Zhang X, Gong Z, Helstrom-Lindahl E and Nordberg A (1994) Regulation of α4/32 nicotinic acetylcholine receptors in M10 cells following treatment with nicotinic agents. Neuroreport 6:313-317.